Novo Nordisk

Ziylo Acquired by Novo Nordisk in Deal That Could Exceed US$800m

BRISTOL, England, August 17, 2018 /PRNewswire/ --<p><b>Ziylo</b><b>'</b><b>s t</b><b>echnology</b> <b>platform</b> <b>could a</b><b>ccelerate</b> <b>develop</b><b>ment of</b> <b>groundbreaking treatment for diabetes</b> …

Anthony Davis

Weekly Summary Corporate dividends, name changes, new listings

Changes announced in corporate dividends Aug. 13-Aug. 17.<p>INCREASED DIVIDENDS<p>Atrion 1.35 from 1.20<p>CSP .15 from .11<p>IF Bancorp .125 from .10<p>j2 Global …

Investing

Novo Buys Startup Ziylo in Potential $800 Million Deal

Novo Nordisk A/S, the world’s biggest maker of diabetes drugs, agreed to buy Ziylo Ltd. to develop new forms of insulin that would respond better to …

Diabetes

Denmark's Novo Nordisk buys UK insulin technology pioneer

Novo Nordisk said in a statement it has acquired Bristol-based Ziylo in a deal that could potentially exceed $800 million.<p>Ziylo describes itself as a …

Diabetes

Novo Nordisk's Pricing Pressures Aren't Going Away

Payers continue to seek lower drug prices from the diabetes expert.<p>There wasn't anything in <b>Novo Nordisk</b>'s (NYSE:NVO) second-quarter results to get …

Profit

The Zacks Analyst Blog Highlights: Novo Nordisk, J&J, Allergan, Editas, AstraZeneca, Merck and Bristol-Myers

<b>For Immediate Release</b><p>Chicago, IL –August 13, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity …

Administrative Law

USA Triathlon, NormaTec Renew Recovery Therapy Partnership Through 2021

USA Triathlon extended its partnership with NormaTec last week. The compression therapy firm will be USA Triathlon’s exclusive recovery partner until …

Sports Technology

Diabetes And Upcoming REWIND Data Key Topics Of Debate For Eli Lilly

Will Eli Lilly's stock outperformance continue?<p>Eli Lilly (LLY) has been on a tear with the stock increasing 37% since late March. More broadly, the …

Eli Lilly

Research Gaps in Gestational Diabetes Mellitus: Executive... : Obstetrics & Gynecology

Diabetes Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; the Divisions of Endocrinology, Metabolism, and …

Southern California

Novo Nordisk to buy back up to DKK2.4B of shares

Novo Nordisk (NYSE:NVO) launches the repurchase of up to DKK2.4B of its B shares. The initiative, part of its DKK14B plan, will be in effect until …

Business

Kala Pharmaceuticals misses by $0.10

Kala Pharmaceuticals (NASDAQ:KALA): Q2 EPS of -$0.60 misses by $0.10.<p>Press Release<p>Now read: <b>Novo Nordisk: Don't Sweat The Market's Reaction, Earnings</b> …

Business

Novo Nordisk: 2Q Earnings Snapshot

BAGSVAERD, Denmark (AP) _ Novo Nordisk A/S (NVO) on Wednesday reported second-quarter earnings of $1.66 billion.<p>On a per-share basis, the Bagsvaerd, …

Snapshot

Shares in Novo Nordisk fall after warning on US price cuts | Financial Times

Shares in Novo Nordisk fell nearly 5 per cent amid concerns that the world’s biggest maker of insulin is being squeezed by pricing pressures in the …

Profit

Novo Nordisk A/S 2018 Q2 - Results - Earnings Call Slides

The following slide deck was published by Novo Nordisk A/S in conjunction with their 2018 Q2 earnings call.<p>119<p>Click to enlarge

Business

Novo Nordisk sees lower US prices next year; second-quarter profit in line with forecasts

Denmark's Novo Nordisk, the world's top maker of diabetes drugs, posted second-quarter operating profit broadly in line with forecasts on Wednesday, …

Profit

Novo Nordisk CEO Sees Demand for Better Products – Bloomberg

QuickTakes<p>Bloomberg QuickTake provides context and background on issues of interest.<p>More episodes and clips<p>03:25How a Bribe-Taking U.S. Informant …

David Rubenstein

Falling US prices pull down Danish Novo Nordisk shares

The group said its 2019 "average prices after rebates are expected to be lower" compared to 2018 in the United States, where it generates almost half …

Denmark

Novo Nordisk A/S (NVO) Q2 2018 Results - Earnings Call Transcript

Novo Nordisk A/S (NYSE:NVO) Q2 2018 Earnings Call August 8, 2018 7:00 AM ET<p><b>Executives</b><p>Lars Fruergaard Jørgensen - Novo Nordisk A/S<p>Mads Krogsgaard …

Markets

A Trade War Haven, European Health Stocks Face Different Test

European health-care stocks have proven something of a haven in President Donald Trump’s escalating trade war this summer, gaining the most of all …

Health Care

Amazon on the rise, Novo Nordisk drops, Tesla dips

Let’s check out the Yahoo Finance charts of the day.<p>Amazon (AMZN): Shares are up in early trade, at around .25%. Amazon is adding a curbside pickup …

Tesla

Hellmann Wins Stage Three but Mugisha Retains Yellow Jersey

[New Times] Team Embrace the World's debutant Julian Hellmann has won stage three of the ongoing 2018 Tour du Rwanda, the longest stage of the annual …

Road Cycling

Corbus Pharmaceuticals beats by $0.01, misses on revenue

Corbus Pharmaceuticals (NASDAQ:CRBP): Q2 EPS of -$0.21 beats by $0.01.<p>Revenue of $0.85M (+142.9% Y/Y) misses by $0.23M.<p>Shares +1.04% PM.<p>Press</b> …

Business

Novo Nordisk: Don't Sweat The Market's Reaction, Earnings Were Solid

On Tuesday, August 8, 2018, diabetes-focused pharmaceutical giant Novo Nordisk (NVO) announced its second-quarter 2018 earnings results. The market …

Business

Novo Nordisk Q2 top line off 4%; earnings up 4%; shares down 5% premarket

Novo Nordisk (NVO) Q2 results (DKK): Revenues: 27,407M (-4.3%); Diabetes Care and Obesity: 23,033M (-3.1%); Biopharmaceuticals: 4,374M …

Diabetes

WellCare prices stock offering at $265; shares down 1% premarket

Wellcare Health Plans (NYSE:WCG) slips 1% premarket on light volume on the heels of its public offering of ~4.5M common shares at $265 per share. …

Business

European shares dip as earnings disappoint

© Reuters. German share price index DAX board is seen at Frankfurt's stock exchange<p>LONDON (Reuters) - European shares dipped on Wednesday as …

Price Index

BMY vs. NVO: Which Stock Is the Better Value Option?

Investors with an interest in Large Cap Pharmaceuticals stocks have likely encountered both Bristol-Myers Squibb (BMY) and Novo Nordisk (NVO). But …

Investing

Team Novo Nordisk's David Lozano Scores Podium Finish at Tour du Rwanda Opener

RWAMAGANA, Rwanda, Aug. 5, 2018 /PRNewswire-PRWeb/ -- Team Novo Nordisk earned a podium finish and its best result of the season when Spaniard David Lozano sprinted to a second place finish on Stage 1 of the Tour du Rwanda.<p>"We are proud to show every person – with and without diabetes – what is …

Road Bikes

Early Beta Cell Function Recovery May Underpin T2D Remission

Type 2 diabetes (T2D) patients who achieve remission following weight loss recover their pancreatic beta cell function early on and maintain it over …

Diabetes

Novo Nordisk channels '70s 'Magic' in first TV ad for blockbuster-in-waiting Ozempic

Novo Nordisk debuted its first DTC campaign for Type 2 diabetes drug Ozempic this week, setting the promotional stage for its aspiring blockbuster. …

Weight Loss